444 related articles for article (PubMed ID: 19335741)
1. Endothelin receptor antagonists in preclinical models of pulmonary hypertension.
Pullamsetti SS; Schermuly RT
Eur J Clin Invest; 2009 Jun; 39 Suppl 2():3-13. PubMed ID: 19335741
[TBL] [Abstract][Full Text] [Related]
2. Endothelin receptor antagonists.
Motte S; McEntee K; Naeije R
Pharmacol Ther; 2006 Jun; 110(3):386-414. PubMed ID: 16219361
[TBL] [Abstract][Full Text] [Related]
3. Endothelin receptor antagonism in pulmonary arterial hypertension--a role for selective ET(A) inhibition?
Jacobs A; Preston IR; Gomberg-Maitland M
Curr Med Res Opin; 2006 Dec; 22(12):2567-74. PubMed ID: 17166339
[TBL] [Abstract][Full Text] [Related]
4. Role of endothelin receptor antagonists in the treatment of pulmonary arterial hypertension.
Abman SH
Annu Rev Med; 2009; 60():13-23. PubMed ID: 18764741
[TBL] [Abstract][Full Text] [Related]
5. The science of endothelin-1 and endothelin receptor antagonists in the management of pulmonary arterial hypertension: current understanding and future studies.
Davie NJ; Schermuly RT; Weissmann N; Grimminger F; Ghofrani HA
Eur J Clin Invest; 2009 Jun; 39 Suppl 2():38-49. PubMed ID: 19335746
[TBL] [Abstract][Full Text] [Related]
6. Endothelin as a clinical target in the treatment of systemic hypertension.
Prasad VS; Palaniswamy C; Frishman WH
Cardiol Rev; 2009; 17(4):181-91. PubMed ID: 19525680
[TBL] [Abstract][Full Text] [Related]
7. Endothelin receptor selectivity in chronic kidney disease: rationale and review of recent evidence.
Neuhofer W; Pittrow D
Eur J Clin Invest; 2009 Jun; 39 Suppl 2():50-67. PubMed ID: 19335747
[TBL] [Abstract][Full Text] [Related]
8. Current status of endothelin blockade for the treatment of cardiovascular and pulmonary vascular disease.
Krum H; Liew D
Curr Opin Investig Drugs; 2003 Mar; 4(3):298-302. PubMed ID: 12744222
[TBL] [Abstract][Full Text] [Related]
9. [Nitric oxide and endothelins in pulmonary hypertension].
Aoki Y; Saji T
Nihon Rinsho; 2001 Jun; 59(6):1059-64. PubMed ID: 11411113
[TBL] [Abstract][Full Text] [Related]
10. Early increase in pulmonary vascular reactivity with overexpression of endothelin-1 and vascular endothelial growth factor in canine experimental heart failure.
Ray L; Mathieu M; Jespers P; Hadad I; Mahmoudabady M; Pensis A; Motte S; Peters IR; Naeije R; McEntee K
Exp Physiol; 2008 Mar; 93(3):434-42. PubMed ID: 17993509
[TBL] [Abstract][Full Text] [Related]
11. Role of endothelin in cardiovascular disease.
Agapitov AV; Haynes WG
J Renin Angiotensin Aldosterone Syst; 2002 Mar; 3(1):1-15. PubMed ID: 11984741
[TBL] [Abstract][Full Text] [Related]
12. Role of endothelin and endothelin receptor antagonists in renal disease.
Neuhofer W; Pittrow D
Eur J Clin Invest; 2006 Sep; 36 Suppl 3():78-88. PubMed ID: 16919017
[TBL] [Abstract][Full Text] [Related]
13. CPU0213, a non-selective ETA/ETB receptor antagonist, improves pulmonary arteriolar remodeling of monocrotaline-induced pulmonary hypertension in rats.
Cui B; Cheng YS; Dai DZ; Li N; Zhang TT; Dai Y
Clin Exp Pharmacol Physiol; 2009 Feb; 36(2):169-75. PubMed ID: 18986320
[TBL] [Abstract][Full Text] [Related]
14. [Endothelin receptor antagonists in pulmonary arterial hypertension].
Tokgöz HC; Can MM; Kaymaz C
Anadolu Kardiyol Derg; 2010 Sep; 10 Suppl 2():9-15. PubMed ID: 20819750
[TBL] [Abstract][Full Text] [Related]
15. Endothelin receptor antagonists for pulmonary arterial hypertension: an overview.
Raja SG
Cardiovasc Ther; 2010 Oct; 28(5):e65-71. PubMed ID: 20406243
[TBL] [Abstract][Full Text] [Related]
16. The role of endothelin in heart failure and hypertension.
Nguyen BN; Johnson JA
Pharmacotherapy; 1998; 18(4):706-19. PubMed ID: 9692645
[TBL] [Abstract][Full Text] [Related]
17. Rescue of pulmonary hypertension with an oral sulfonamide antibiotic sulfisoxazole by endothelin receptor antagonistic actions.
Uchino T; Sanyal SN; Yamabe M; Kaku T; Takebayashi S; Shimaoka T; Shimada T; Noguchi T; Ono K
Hypertens Res; 2008 Sep; 31(9):1781-90. PubMed ID: 18971557
[TBL] [Abstract][Full Text] [Related]
18. [Endothelins in chronic cardiac insufficiency].
Pousset F
Arch Mal Coeur Vaiss; 1998 Dec; 91(12 Suppl):23-6. PubMed ID: 9891817
[TBL] [Abstract][Full Text] [Related]
19. Myocardial effects of ETB receptor stimulation.
Leite-Moreira AF; Brás-Silva C; Pedrosa C
Rev Port Cardiol; 2002 Sep; 21(9):1009-16. PubMed ID: 12416272
[TBL] [Abstract][Full Text] [Related]
20. Vascular endothelin in hypertension.
Schiffrin EL
Vascul Pharmacol; 2005 Jun; 43(1):19-29. PubMed ID: 15955745
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
